Hans van Houte
Senior Vice President, Finance
Hans van Houte is Vice President, Finance at Nurix. Prior to joining, Mr. van Houte served as acting CFO for multiple new biotechnology companies formed with investments totaling over $150 million from Third Rock Ventures and The Column Group. Mr. van Houte previously held senior financial roles in biotechnology companies including Vice President, Finance and Administration at Trubion Pharmaceuticals where he was part of the team that took Trubion public in October 2006. Prior to Trubion Mr. van Houte was the Controller, Treasurer and Principal Accounting Officer at Vertex Pharmaceuticals, where he helped build the financial and accounting organization post-IPO to support growth from a $100 million to a multibillion market capitalization. Mr. van Houte received a B.S. in Business Management from Babson College.